Tyler Zeronda
Director of Finance/CFO at VYNE THERAPEUTICS INC.
Net worth: 404 451 $ as of 2024-03-30
Profile
Tyler Zeronda is currently the Chief Financial Officer & Treasurer at VYNE Therapeutics, Inc. He previously worked as the Director-Finance at Aerie Pharmaceuticals, Inc. Mr. Zeronda holds a graduate degree from the University of Virginia and an undergraduate degree from Lafayette College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VYNE THERAPEUTICS INC
0.93% | 2024-03-31 | 131,743 ( 0.93% ) | 404 451 $ | 2024-03-30 |
Tyler Zeronda active positions
| Companies | Position | Start |
|---|---|---|
| VYNE THERAPEUTICS INC. | Director of Finance/CFO | 2021-06-17 |
Former positions of Tyler Zeronda
| Companies | Position | End |
|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Training of Tyler Zeronda
| University of Virginia | Graduate Degree |
| Lafayette College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VYNE THERAPEUTICS INC. | Health Technology |
| Private companies | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Stock Market
- Insiders
- Tyler Zeronda
